Morpholino

MO1-ahrra

ID

ZDB-MRPHLNO-100513-5

Name

MO1-ahrra

Previous Names

None

Target

ahrra (1)

Sequence

5' - ATCCTCAAGATGCCTGCTGTGTGTG - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO1-ahrra

Expressed Gene	Anatomy	Figures
arr3b	whole organism	Fig. 3, Fig. 4 from Aluru et al., 2014
hbbe3	whole organism	Fig. 3, Fig. 4 from Aluru et al., 2014
mmp9	whole organism	Fig. 3, Fig. 4 from Aluru et al., 2014
opn1sw1	whole organism	Fig. 3, Fig. 4 from Aluru et al., 2014
pde6c	whole organism	Fig. 3, Fig. 4 from Aluru et al., 2014
pde6ha	whole organism	Fig. 3, Fig. 4 from Aluru et al., 2014

Phenotype

Phenotype resulting from MO1-ahrra

Phenotype	Fish	Figures
cranium malformed, abnormal	TL + MO1-ahrra	Fig. 7 from Jenny et al., 2009
heart deformed, abnormal	TL + MO1-ahrra	Fig. 7 from Jenny et al., 2009
pericardium edematous, abnormal	TL + MO1-ahrra	Fig. 7, Fig. 8 from Jenny et al., 2009
whole organism pde6ha expression decreased amount, abnormal	TL + MO1-ahrra	Fig. 3, Fig. 4 from Aluru et al., 2014
whole organism pde6c expression decreased amount, abnormal	TL + MO1-ahrra	Fig. 3, Fig. 4 from Aluru et al., 2014
whole organism opn1sw1 expression decreased amount, abnormal	TL + MO1-ahrra	Fig. 3, Fig. 4 from Aluru et al., 2014
whole organism arr3b expression decreased amount, abnormal	TL + MO1-ahrra	Fig. 3, Fig. 4 from Aluru et al., 2014
whole organism hbbe3 expression increased amount, abnormal	TL + MO1-ahrra	Fig. 3, Fig. 4 from Aluru et al., 2014
yolk edematous, abnormal	TL + MO1-ahrra	Fig. 7 from Jenny et al., 2009

Phenotype of all Fish created by or utilizing MO1-ahrra

Phenotype	Fish	Conditions	Figures
pericardium edematous, abnormal	TL + MO1-ahrra	standard conditions	Fig. 7, Fig. 8 from Jenny et al., 2009
whole organism hbbe3 expression increased amount, abnormal	TL + MO1-ahrra	control	Fig. 3, Fig. 4 from Aluru et al., 2014
heart deformed, abnormal	TL + MO1-ahrra	standard conditions	Fig. 7 from Jenny et al., 2009
whole organism opn1sw1 expression decreased amount, abnormal	TL + MO1-ahrra	control	Fig. 3, Fig. 4 from Aluru et al., 2014
pericardium edematous, abnormal	TL + MO1-ahrra	chemical treatment: 2,3,7,8-tetrachlorodibenzodioxine	Fig. 8 from Jenny et al., 2009
yolk edematous, abnormal	TL + MO1-ahrra	standard conditions	Fig. 7 from Jenny et al., 2009
whole organism arr3b expression decreased amount, abnormal	TL + MO1-ahrra	control	Fig. 3, Fig. 4 from Aluru et al., 2014
whole organism arr3b expression decreased amount, abnormal	TL + MO1-ahrra	chemical treatment: 2,3,7,8-tetrachlorodibenzodioxine	Fig. 4 from Aluru et al., 2014
whole organism pde6c expression decreased amount, abnormal	TL + MO1-ahrra	chemical treatment: 2,3,7,8-tetrachlorodibenzodioxine	Fig. 4 from Aluru et al., 2014
whole organism hbbe3 expression increased amount, abnormal	TL + MO1-ahrra	chemical treatment: 2,3,7,8-tetrachlorodibenzodioxine	Fig. 4 from Aluru et al., 2014
whole organism pde6c expression decreased amount, abnormal	TL + MO1-ahrra	control	Fig. 3, Fig. 4 from Aluru et al., 2014
whole organism pde6ha expression decreased amount, abnormal	TL + MO1-ahrra	chemical treatment: 2,3,7,8-tetrachlorodibenzodioxine	Fig. 4 from Aluru et al., 2014
whole organism pde6ha expression decreased amount, abnormal	TL + MO1-ahrra	control	Fig. 3, Fig. 4 from Aluru et al., 2014
cranium malformed, abnormal	TL + MO1-ahrra	standard conditions	Fig. 7 from Jenny et al., 2009
whole organism opn1sw1 expression decreased amount, abnormal	TL + MO1-ahrra	chemical treatment: 2,3,7,8-tetrachlorodibenzodioxine	Fig. 4 from Aluru et al., 2014

Citations